查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930044

移植市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察与预测（2025-2034）

Transplantation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 161 Pages | 商品交期: 请询问到货日

价格

移植市场成长驱动因素

全球移植市场涵盖与器官和组织移植相关的医疗程序和产品，包括肾臟、肝臟、心臟、肺臟、角膜、皮肤、骨骼和肌腱。移植在挽救因慢性疾病、创伤、中毒、失血、白血病、败血症和其他急性疾病导致的器官衰竭患者的生命方面发挥着至关重要的作用。对器官移植手术需求的不断增长，以及公众意识的提高和技术创新，正显着推动市场成长。

市场规模及预测

根据 Fortune Business Insights 的数据，2025 年全球器官移植市场规模为 119.3 亿美元。预计到 2026 年将成长至 130.1 亿美元，到 2034 年将达到 285.7 亿美元，在预测期（2026-2034 年）内，复合年增长率 (CAGR) 为 10.33%。

北美地区在 2025 年将占市场主导地位，市场占有率为 42.29%，这得益于其先进的医疗基础设施、优惠的报销政策以及众多的器官捐赠项目。此外，预计到2032年，美国器官移植市场规模将达到85.4亿美元，主要得益于器官捐赠率的提高和技术的进步。

市场驱动因素

市场成长的关键驱动因素是全球对器官移植需求的不断增长。癌症、肾衰竭、慢性阻塞性肺病（COPD）和狼疮等慢性疾病的日益普遍，显着增加了器官衰竭病例的数量。

例如，根据美国卫生资源与服务管理局（HRSA）的数据，截至2024年2月，美国国家器官移植等待名单上的人数超过10.3万人。此外，2023年美国进行了超过4.6万例器官移植手术，凸显了此类手术的强劲需求。

此外，政府和非政府组织所进行的提高器官捐赠意识的措施也推动了市场扩张。诸如印度器官捐赠组织 (ORGAN India) 和英国国家医疗服务体系 (NHS) 等机构积极开展鼓励捐赠者登记的活动，从而提高了器官移植率。

新冠疫情的影响

由于择期手术减少、严格的安全指南以及医院就诊量下降，新冠疫情对器官移植市场造成了负面影响，尤其是在 2020 年。全球器官移植手术数量的下降也影响了主要市场参与者的销售额。

然而，到 2022 年底，随着医院恢復运作和器官捐赠意识的提高，市场逐渐復苏。策略研究措施和新产品的推出有助于市场在 2024 年恢復到疫情前的成长轨迹，并支撑了 2025 年至 2032 年的稳定成长。

市场趋势

影响器官移植市场的关键趋势之一是公共和私营部门利害关係人之间合作的加强。这些合作旨在提高器官捐赠率、加强移植基础设施建设并简化供体-受体匹配流程。

例如，移植治疗联盟 (TTC) 透过与产业参与者、学术机构和监管机构合作，加速移植相关领域的创新。同样，涉及泛美卫生组织 (PAHO) 和西班牙政府等组织的国际合作正在加强各地区的移植生态系统。

成长因素

另一个关键的成长因素是组织工程和保存技术的进步。 3D 生物列印、基于干细胞的组织再生和异种移植等创新技术有助于缓解捐赠者短缺问题并降低排斥风险。

例如，2023 年 6 月，3D BioFibR 公司宣布推出一种用于组织和器官生物列印的新型胶原蛋白基生物墨水产品。这些技术进步拓展了治疗的可能性，并支持市场的长期成长。

限制因子

儘管市场成长前景强劲，但器官移植等待时间的延长给市场带来了挑战。根据美国捐赠生命组织（Donate Life America）统计，美国平均每八分钟就有一人被列入器官移植等待名单，肾臟移植的平均等待时间为三至五年。

在发展中国家，认知度低、保险报销不足以及移植基础设施匮乏进一步限制了市场成长。这些因素持续阻碍器官移植的广泛应用。

细分市场分析

  • 依产品类型：免疫抑制剂细分市场占主导地位，预计到2026年将占43.18%的市场占有率，这主要得益于其在预防器官排斥反应方面的重要作用。
  • 按应用领域：组织移植细分市场预计到2026年将占63.88%的市场占有率，这主要得益于角膜移植和皮肤移植等手术量的激增。
  • 按最终用户划分：医院在2026年将以60.06%的市场占有率领先，这主要得益于其作为复杂移植手术主要中心的地位。

区域洞察

北美地区预计在2025年将占50.4亿美元的市场占有率，凭藉先进的技术和强有力的监管支持，将继续保持市场领先地位。欧洲将保持其第二大市场占有率，这得益于教育活动和不断增长的手术量。亚太地区正经历快速成长，这主要归功于慢性病盛行率的上升和医疗基础设施的改善，尤其是在中国、日本和印度。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家主要器官移植量（2025 年）
  • 主要产业趋势－併购与合作
  • 监理环境概述
  • 新冠疫情对市场的影响

第五章：全球移植市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 按产品类型划分
    • 组织产品
    • 免疫抑制剂
    • 保存液
  • 市场分析、洞察与预测 - 按应用划分
    • 器官移植
    • 组织移植
  • 市场分析、洞察与预测 - 按最终用户划分
    • 医院
    • 移植中心
    • 其他
  • 市场分析、洞察与预测 - 按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美移植市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲移植市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章 亚太地区移植市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚亚洲
    • 亚太其他地区

第九章 拉丁美洲移植市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章 中东与非洲移植市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲国家

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司型材
    • 诺华公司
    • 梯瓦製药工业股份有限公司
    • Arthrex 公司
    • Veloxis Pharmaceuticals, Inc.（旭化成株式会社）
    • 生物生命解决方案
    • 跨医疗公司
    • F.霍夫曼-拉罗氏有限公司
    • Zimmer Biomet
    • 安斯泰来药厂
Product Code: FBI105049

Growth Factors of transplantation Market

The global transplantation market comprises medical procedures and products related to the transplantation of organs and tissues, including kidneys, liver, heart, lungs, cornea, skin, bones, and tendons. Transplantation plays a critical role in saving lives affected by organ failure caused by chronic diseases, trauma, poisoning, blood loss, leukemia, sepsis, and other acute conditions. Rising demand for transplant procedures, coupled with increasing awareness and technological innovation, is significantly driving the market's growth.

Market Size and Forecast

According to Fortune Business Insights, the global transplantation market was valued at USD 11.93 billion in 2025. It is projected to grow to USD 13.01 billion in 2026 and further expand to USD 28.57 billion by 2034, registering a CAGR of 10.33% during the forecast period (2026-2034).

North America dominated the market with a 42.29% share in 2025, supported by advanced healthcare infrastructure, favorable reimbursement policies, and a high number of organ donation programs. Additionally, the U.S. transplantation market is projected to reach USD 8.54 billion by 2032, driven by increasing organ donation rates and technological advancements.

Market Drivers

A key factor driving market growth is the increasing demand for transplantation procedures worldwide. The rising prevalence of chronic conditions such as cancer, kidney failure, chronic obstructive pulmonary disease (COPD), and lupus has significantly increased organ failure cases.

For instance, according to the U.S. Health Resources & Services Administration, over 103,000 individuals were on the U.S. national organ transplant waiting list in February 2024. Furthermore, in 2023, more than 46,000 organ transplant procedures were performed in the U.S., highlighting strong procedural demand.

In addition, government and non-government initiatives promoting organ donation awareness are boosting market expansion. Organizations such as ORGAN India and the National Health Service (NHS) in the U.K. actively run campaigns encouraging donor registration, thereby increasing transplantation rates.

COVID-19 Impact

The COVID-19 pandemic negatively impacted the transplantation market, particularly during 2020, due to reduced elective procedures, strict safety guidelines, and fewer hospital visits. Transplant procedures declined globally, affecting the sales of key market players.

However, the market gradually recovered by the end of 2022, as hospital operations resumed and awareness regarding organ donation increased. Strategic research initiatives and new product launches helped the market return to its pre-pandemic growth trajectory by 2024, supporting stable growth during 2025-2032.

Market Trends

One of the major trends shaping the transplantation market is the increase in collaborations between public and private stakeholders. These collaborations aim to improve organ donation rates, enhance transplant infrastructure, and streamline donor-recipient matching processes.

For example, the Transplant Therapeutics Consortium (TTC) collaborates with industry players, academic institutions, and regulatory agencies to accelerate transplant-related innovations. Similarly, international collaborations involving organizations such as PAHO and the Government of Spain are strengthening transplant ecosystems across regions.

Growth Factors

Another significant growth driver is the advancement in tissue engineering and preservation technologies. Innovations such as 3D bioprinting, stem cell-based tissue regeneration, and xenotransplantation are addressing donor shortages and reducing rejection risks.

For instance, in June 2023, 3D BioFibR launched novel collagen-based bio-ink products for tissue and organ bioprinting. These technological advancements are expanding treatment possibilities and supporting long-term market growth.

Restraining Factors

Despite strong growth prospects, the market faces challenges due to prolonged waiting periods for transplant procedures. According to Donate Life America, one person is added to the U.S. transplant waiting list every 8 minutes, and the average waiting time for kidney transplantation ranges from 3 to 5 years.

In developing countries, limited awareness, inadequate reimbursement policies, and insufficient transplant infrastructure further restrict market growth. These factors continue to act as barriers to widespread adoption.

Segmentation Analysis

  • By Product Type: The immunosuppressive drugs segment dominated the market with a 43.18% share in 2026, owing to their essential role in preventing organ rejection.
  • By Application: The tissue transplantation segment held a 63.88% market share in 2026, driven by the high volume of procedures such as corneal and skin transplants.
  • By End-user: Hospitals led the market with a 60.06% share in 2026, as they remain primary centers for complex transplant procedures.

Regional Insights

North America accounted for USD 5.04 billion in 2025 and continues to dominate due to advanced technologies and strong regulatory support. Europe holds the second-largest share, supported by awareness initiatives and increasing procedures. Asia Pacific is witnessing rapid growth due to rising chronic disease prevalence and improving healthcare infrastructure, particularly in China, Japan, and India.

Competitive Landscape

The market is moderately fragmented, with leading players such as Zimmer Biomet, Astellas Pharma, BioLife Solutions, Novartis AG, TransMedics, and Roche. These companies focus on product innovation, strategic partnerships, and acquisitions to strengthen their market position.

Conclusion

In conclusion, the global transplantation market is expected to grow from USD 11.93 billion in 2025 to USD 28.57 billion by 2034, driven by rising organ failure cases, increasing transplant procedures, supportive government initiatives, and continuous technological advancements. While challenges such as donor shortages and long waiting periods persist, expanding awareness programs, innovation in tissue engineering, and strong collaboration among stakeholders are expected to sustain robust market growth throughout the forecast period.

Segmentation By Product Type

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solutions

By Application

  • Organ Transplantation
  • Tissue Transplantation

By End-user

  • Hospitals
  • Transplantation Centers
  • Others

By Region

  • North America (By Product Type, Application, End-user, and Country/Sub-Region)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product Type, Application, End-user, and Country/Sub-Region)
    • Germany (By Application)
    • France (By Application)
    • U.K. (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product Type, Application, End-user, and Country/Sub-Region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Product Type, Application, End-user, and Country/Sub-Region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-Region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Number of Major Organ Transplantation, By Key Countries, 2025
  • 4.2. Key Industry Developments- Mergers, Acquisitions and Partnerships
  • 4.3. Overview of Regulatory Scenario
  • 4.4. Impact of COVID-19 on the Market

5. Global Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Tissue Products
    • 5.1.2. Immunosuppressive Drugs
    • 5.1.3. Preservation Solutions
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Organ Transplantation
    • 5.2.2. Tissue Transplantation
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Transplantation Centers
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Tissue Products
    • 6.1.2. Immunosuppressive Drugs
    • 6.1.3. Preservation Solutions
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Organ Transplantation
    • 6.2.2. Tissue Transplantation
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Transplantation Centers
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Tissue Products
    • 7.1.2. Immunosuppressive Drugs
    • 7.1.3. Preservation Solutions
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Organ Transplantation
    • 7.2.2. Tissue Transplantation
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Transplantation Centers
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
      • 7.4.1.1. By Application
    • 7.4.2. France
      • 7.4.2.1. By Application
    • 7.4.3. U.K.
      • 7.4.3.1. By Application
    • 7.4.4. Italy
      • 7.4.4.1. By Application
    • 7.4.5. Spain
      • 7.4.5.1. By Application
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Application
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Application

8. Asia Pacific Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Tissue Products
    • 8.1.2. Immunosuppressive Drugs
    • 8.1.3. Preservation Solutions
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Organ Transplantation
    • 8.2.2. Tissue Transplantation
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Transplantation Centers
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
      • 8.4.1.1. By Application
    • 8.4.2. Japan
      • 8.4.2.1. By Application
    • 8.4.3. India
      • 8.4.3.1. By Application
    • 8.4.4. Australia
      • 8.4.4.1. By Application
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Tissue Products
    • 9.1.2. Immunosuppressive Drugs
    • 9.1.3. Preservation Solutions
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Organ Transplantation
    • 9.2.2. Tissue Transplantation
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Transplantation Centers
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Transplantation Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Tissue Products
    • 10.1.2. Immunosuppressive Drugs
    • 10.1.3. Preservation Solutions
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Organ Transplantation
    • 10.2.2. Tissue Transplantation
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals
    • 10.3.2. Transplantation Centers
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Novartis AG
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Teva Pharmaceutical Industries Ltd.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Arthrex, Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. BioLife Solutions
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. TransMedics
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. F. Hoffmann-La Roche Ltd
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Zimmer Biomet
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Astellas Pharma Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 02: Global Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 03: Global Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 04: Global Transplantation Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 05: North America Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 06: North America Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 07: North America Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 08: North America Transplantation Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 09: U.S. Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 10: Canada Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: Europe Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 12: Europe Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: Europe Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 14: Europe Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 15: Germany Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 16: France Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 17: U.K. Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: Italy Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Spain Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Scandinavia Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 21: Rest of Europe Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 23: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 25: Asia Pacific Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 26: China Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Japan Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: India Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Australia Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 30: Southeast Asia Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Rest of Asia-Pacific Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 32: Latin America Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 33: Latin America Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Latin America Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 35: Latin America Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 36: Brazil Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 37: Mexico Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Rest of Latin America Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 39: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 40: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By End-user, 2021-2034
  • Table 42: Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 43: GCC Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 44: South Africa Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 45: Rest of Middle East & Africa Transplantation Market Revenue (USD billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 01: Global Transplantation Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034
  • Figure 02: Global Transplantation Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 03: Global Transplantation Market Value Share (%), By Application, 2025 & 2034
  • Figure 04: Global Transplantation Market Value Share (%), By End-user, 2025 & 2034
  • Figure 05: Global Transplantation Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 07: North America Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 08: North America Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 09: North America Transplantation Market Value Share (%), By Application, 2025
  • Figure 10: North America Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 11: North America Transplantation Market Value Share (%), By End-user, 2025
  • Figure 12: North America Transplantation Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Transplantation Market Value Share (%), By Country, 2025
  • Figure 14: Europe Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 15: Europe Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 16: Europe Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 17: Europe Transplantation Market Value Share (%), By Application, 2025
  • Figure 18: Europe Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 19: Europe Transplantation Market Value Share (%), By End-user, 2025
  • Figure 20: Europe Transplantation Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe Transplantation Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 22: Asia Pacific Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 24: Asia Pacific Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 25: Asia Pacific Transplantation Market Value Share (%), By Application, 2025
  • Figure 26: Asia Pacific Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 27: Asia Pacific Transplantation Market Value Share (%), By End-user, 2025
  • Figure 28: Asia Pacific Transplantation Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Transplantation Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 30: Latin America Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 31: Latin America Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 32: Latin America Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 33: Latin America Transplantation Market Value Share (%), By Application, 2025
  • Figure 34: Latin America Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 35: Latin America Transplantation Market Value Share (%), By End-user, 2025
  • Figure 36: Latin America Transplantation Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 37: Latin America Transplantation Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 38: Middle East & Africa Transplantation Market Value (USD billion), By Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Transplantation Market Value Share (%), By Product Type, 2025
  • Figure 40: Middle East & Africa Transplantation Market Value (USD billion), By Application, 2025 & 2034
  • Figure 41: Middle East & Africa Transplantation Market Value Share (%), By Application, 2025
  • Figure 42: Middle East & Africa Transplantation Market Value (USD billion), By End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Transplantation Market Value Share (%), By End-user, 2025
  • Figure 44: Middle East & Africa Transplantation Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Transplantation Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 46: Global Transplantation Market Share Analysi (%), By Company, 2025